Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients

BACKGROUND: The chemotherapy resistance and toxicity of chemotherapy are major problems in breast cancer treatment. However, candidate biomarkers for predicting clinical outcomes and better prognosis remain lacking. METHODS: In this study, we analyzed possible impact of 8 genetic variants of fibrobl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Chen, Lu, Qi, Huijie, Zhang, Liudi, Li, Haixia, Shao, Jie, Chen, Haifei, Zhong, Mingkang, Shi, Xiaojin, Ye, Ting, Li, Qunyi
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2018
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6202826/
https://ncbi.nlm.nih.gov/pubmed/30359238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4951-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares